The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTP.L Regulatory News (CTP)

  • There is currently no data for CTP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Feb 2019 16:43

RNS Number : 1660P
Castleton Technology PLC
05 February 2019
 

TR-1: Standard form for notification of major holdings

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Castleton Technology PLC

1b. Please indicate if the issuer is a non-UK issuer

Non-UK issuer

2. Reason for the notification

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Kestrel Partners LLP

City and country of registered office (if applicable)

LONDON, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

Kestrel Opportunities, a cell of Guernsey Portfolios PCC Ltd (through BNY Mellon Nominees Limited) and various other clients of Kestrel Partners LLP (through JIM Nominees Ltd and Bank of New York Nominees Ltd)

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

1 February 2019

6. Date on which issuer notified:

5 February 2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

16.55%

16.55%

81,332,434

Position of previous notification (if

applicable)

17.75%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares of 2p each

ISIN GB00BYV2WV72

N/A

13,460,275

N/A

16.55%

SUBTOTAL 8. A

13,460,275

16.55%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BNY Mellon Nominees Limited

10.55%

10.55%

Bank of New York Nominees Limited

3.55%

3.55%

JIM Nominees Limited

2.45%

2.45%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

The indirect voting rights held under (9) relate to shares held in client portfolios managed by Kestrel Partners LLP under discretionary investment management agreements

 

Place of completion

London

Date of completion

05/02/19

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUVONRKKAURAR
Date   Source Headline
7th Mar 20177:00 amRNSDirector Dealings/ Holdings in Company
6th Mar 20177:00 amRNSDirector Dealings/Holdings in Company
2nd Mar 20177:00 amRNSDirector Dealings & Holdings in Company
8th Feb 20173:54 pmRNSHolding(s) in Company
27th Jan 20177:00 amRNSDirector Dealings/ Holdings in Company
19th Jan 20174:21 pmRNSHolding(s) in Company
19th Jan 20174:20 pmRNSDirector/PDMR Shareholding
16th Jan 20177:01 amRNSDirectorate Change
16th Jan 20177:00 amRNSContract Wins
21st Dec 20169:18 amRNSHolding(s) in Company
22nd Nov 20164:28 pmRNSHolding(s) in Company
15th Nov 20167:06 amRNSContract Win
14th Nov 201610:00 amRNSGrant of Options
14th Nov 20167:00 amRNSHalf-year Report
31st Oct 20167:00 amRNSBoard Changes
26th Oct 20168:30 amRNSHolding(s) in Company
4th Oct 201611:37 amRNSIssue of Equity/Conversion of Loan Notes
29th Sep 20164:06 pmRNSResult of AGM
26th Sep 20164:32 pmRNSHolding(s) in Company
9th Sep 20167:00 amRNSPosting of Annual Report and Notice of AGM
31st Aug 20167:00 amRNSDirectorate Change
16th Aug 20167:00 amRNSFinal Results
5th Jul 20164:36 pmRNSIssue of Equity/Conversion of Loan Notes
3rd May 20164:34 pmRNSHolding(s) in Company
3rd May 20167:00 amRNSTrading Update
21st Apr 20167:00 amRNSHolding(s) in Company
4th Apr 20167:00 amRNSLicense Agreement
29th Mar 20163:04 pmRNSHolding(s) in Company
15th Mar 20167:00 amRNSContract wins
8th Feb 20164:45 pmRNSHolding(s) in Company
1st Feb 20167:00 amRNSAcquisition of Kypera Holdings Limited
28th Jan 20165:26 pmRNSHolding(s) in Company
28th Jan 20165:00 pmRNSHolding(s) in Company
27th Jan 20164:10 pmRNSStatement re Share Price Movement
31st Dec 20157:00 amRNSExercise of Warrants / Issue of Equity
24th Dec 201512:29 pmRNSHolding(s) in Company
24th Dec 20157:00 amRNSGrant of Options
17th Dec 20154:56 pmRNSHolding(s) in Company
16th Dec 20157:00 amRNSIssue of Equity / Conversion of Loan Notes
15th Dec 20157:00 amRNSHalf Yearly Report
15th Dec 20157:00 amRNSFurther re: Acquisition of Opus
2nd Nov 20157:00 amRNSAppointment of Director
22nd Oct 20154:20 pmRNSResult of AGM and Capital Reorganisation
22nd Oct 20157:00 amRNSTrading Update
13th Oct 20154:25 pmRNSHolding(s) in Company
1st Oct 201512:13 pmRNSExercise of Options / Issue of Equity
30th Sep 20154:41 pmRNSProposed Capital Reorganisation
21st Sep 20157:00 amRNSFinal Results
14th Sep 20153:25 pmRNSPartnership with solutions supplier
2nd Sep 20155:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.